BPDCN are characterized by frequent complex karyotypes with recurrent MYB/MYC rearrangements as well as recurrent deletions involving ETV6, IKZF1, RB1, and TP53 loci. The gene discussed is MYC; the disease is CD4+/CD56+ hematodermic neoplasm.